S02 36C25722Q0466 Source Sought Notice - AMA Coagulation CPRR.docx

DOCX document 50 KB Posted

Attached to
Amarillo Coagulation CPRR
Solicitation number
36C25722Q0466
Issued by

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Sources Sought Notice Sources Sought Notice

SUBJECT*
Amarillo Coagulation CPRR

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
78240
SOLICITATION NUMBER*
36C25722Q0466
RESPONSE DATE/TIME/ZONE
04-05-2022 16:00 CENTRAL TIME, CHICAGO, USA
ARCHIVE
30 DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
N

SET-ASIDE

PRODUCT SERVICE CODE*
6550
NAICS CODE*
334516
CONTRACTING OFFICE ADDRESS
Department Of Veterans Affairs

Network Contracting Office 17

5441 Babcock Road Ste. 302 San Antonio TX 78240

POINT OF CONTACT*

Contracting Officer Robyn Nussbaum robyn.nussbaum@va.gov

PLACE OF PERFORMANCE

ADDRESS
Department of Veterans Affairs

P&LMS Section

6010 Amarillo Blvd West

Amarillo TX

POSTAL CODE
79106
COUNTRY
USA

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

The Amarillo VA Health Care System (AVAHCS) in Amarillo, Texas is seeking Service-Disabled Veteran Owned Small Business (SDVOSB), Veteran Owned Small Business (VOSB), or Small Business sources capable of meeting the requirement listed below. The acquisition will be accomplished using commercial item procedures in accordance with FAR Part 12.

NOTE: TO QUALIFY SDVOSB AND VOSB VENDORS MUST BE CERTIFIED IN THE VA VENDOR INFORMATION PAGES (VIP) DATABASE.

The North American Industry Classification System (NAICS) is 334516. Any SDVOSB, VOSB, or Small Business firms who wish to identify their interests and capability to provide this product must provide product specifications, performance and delivery information by notifying the Contract Specialist no later than 4:00 PM Central Time, April 5, 2022. Notification shall be e-mailed to Robyn Nussbaum, at robyn.nussbaum@va.gov.

Any vendor who responds to this Notice must provide credentials to perform the requirement as outlined in the below scope.

DISCLAIMER

This Sources Sought Notice is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this Notice that is marked as proprietary will be handled accordingly. In accordance with the Federal Acquisition Regulation, responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this Notice.

1. SCOPE

The intent of the Amarillo Veterans Affairs Health Care System (AVAHCS) Pathology & Laboratory Medicine Service is to provide continuous, accurate, coagulation testing to providers. The desired proposal requires reagents, quality control materials, and consumables to be provided for approximately 74,000 coagulation tests analyzed over the next 60 months (8-1-2022 through 7-30-2027) on a cost-per-test (CPT) or cost per reportable result (CPRR) basis as an IDIQ for three (3) identical automated analyzers for the following locations:

1.1.Two (2) identical automated analyzers for:
Amarillo VA Health Care System
6010 Amarillo Blvd., West
Amarillo, TX 79106
Attn: Pathology and Laboratory Medicine Service
1.2.One (1) analyzer to be identical to the two (2) automated analyzers in Amarillo.
Lubbock VA CBOC
3510 4th Street
Lubbock, TX 79415
Attn: Pathology and Laboratory Medicine Service

These three (3) identical automated analyzers have been previously procured as a CPRR to perform the following assays on outpatient and inpatient population (associated annual volumes are estimated):

AVAHCS:
PT/INR
aPTT
Fibrinogen

Quantitative D-Dimer

Controls
Controls
Controls
Controls
4380
4380

5 boxes of low control

LUBBOCK CBOC:
PT/INR

aPTT

1500
250
Controls
Controls
900
220

1.3. Background:

1.3.1 The Coagulation Department of the Amarillo VAHCS is a 24/7/365 operation that services the Amarillo area and the 50 surrounding countries in the Texas/Oklahoma Panhandle, New Mexico, and a small portion of Colorado. Amarillo VAHCS has a large outpatient population who visits the Hospital each day, and the four Community Based Outreach Clinics (Lubbock, TX; Childress, TX; Dalhart, TX; and Clovis, NM). Currently, the Amarillo and Lubbock Coagulation Department runs approximately 14,800 coagulation analytes per year and the past several years have seen a decrease in testing due to the SARS- CoV-2 pandemic.

1.3.2 For the past 5 years, the Coagulation Department located in Amarillo, TX has utilized two (2) CS2500 analyzers and one (1) CS2500 analyzer in Lubbock, TX.

1. 4. Performance Period:

1.4.1 See Price/Cost Schedule

1.4.2 Base year + four (4) Option Years

1.5. Type of Contract:

1.5.1 This is a firm fixed price contract for Indefinite Delivery/Indefinite Quantity (IDIQ) to include all reagents, calibrators, consumables, and service to be delivered upon the ordering facility and/or through metering data usage.

1.5.2 The Vendor must provide all equipment, reagents, calibrators, controls, consumable items, parts, accessories, ancillary devices, service plans, shipping costs, installation, validation studies, training, any other item required to establish instrument operation, and should be from the same family of analyzers as applicable and suitable for the facilities listed.

1.6. Amarillo VAHCS Contingency due to remodel of the AMA laboratory

1.6.1 Dependent of the dimensions of the coagulation analyzers, the vendor may be required to come and pick up analyzer(s) that cannot fit into the temporary core laboratory space at no additional charge to the Government due to lack of storage space to house the analyzer. Once remodeled, the analyzer may be re-installed into the laboratory as if there was not disruption of service and/or testing performance.

1.6.2 Suggested timeframe for the laboratory move into the temporary core lab space is projected to be October of 2022 but this time frame can change at any time.

1.6.3 The Lubbock laboratory will not undergo any new remodel during the POP of this contract: therefore, no analyzer(s) pickup will be required.

2. GENERAL REQUIREMENTS FOR COAGULATION EQUIPMENT/ANALYZERS

2.1 Instrumentation shall be from the same family of analyzers as applicable and suitable for the facilities listed.

2.2 The equipment models being offered shall be in current production as of the date this proposal is submitted. For purposes of this solicitation, “current production” shall mean that the clinical laboratory analyzer model is being offered as new equipment. Discontinued models that are only being made available as remanufactured equipment are not acceptable. Consideration of used equipment or current in-house equipment will not be accepted in the proposal.

2.3The Vendor shall provide all upgrades to the equipment hardware and operating system
software at no additional cost to the Government during the lifetime of the instrument.These enhancements shall be delivered and installed within 60 days of issuance to thecommercial market.
2.4All components – instrumentation, middleware, and reagents – shall be compatible with
each other. All components shall be manufactured with the purposeful intent of beingutilized operationally with each other.

2.5 All components –instrumentation, middleware, and reagents – shall be Food and Drug Administration (FDA)-approved.

2.6Instrumentation and reagents shall be able to perform tests to specifications as defined by
CLIA and CLSI standards, including satisfactory CAP peer group comparisons.

2.7 Sufficient capacity and throughput to meet the volume and service demands as defined.

2.8 To be configurable to perform automatic on-board dilutions of all samples with out of range results or defined limits are exceeded.

2.9 Capability to program a test as a repeat with interfacing of results to overlay initial result.

2.10 The ability to continuously load patient specimens.

2.11 Be an open system which can accommodate at least 5 or more user-defined assays with ability of incorporating other manufacturer’s reagents

2.12 The ability to detect short samples and have clot detection with alert notification prior to the sample entering the probes.

2.13 Capable of primary tube sampling from various manufacturers and sizes of evacuated tubes.

2.14Accepts citrated plasma for patient testing only.
2.15Ability to handle all routine sample collection tubes plus other various sized samplecontainers i.e., sample cups (0.5, 1.0, and 2.0 ml), carrier tubes and tube inserts.

2.16 Proven to have “zero to minimal” patient sample carryover.

2.17 Proven to have “zero to minimal” interfering factors that would affect the test results (such as hemolysis, lipemia, icterus, drug interference, etc.)

2.18Have the ability to quantify, at least semi-quantitatively, plasma indices. This includes
hemolysis, icterus, and lipemia. Indices should be reported as 1+ to 4+ and haverespective bias information corresponding to this interference in the assay packageinserts.

2.19 Ability to prioritize STAT testing without compromising existing programmed testing.

2.20 Minimal operator intervention to change a routine specimen to a STAT specimen, as well as introduce STAT specimens during a test run without aborting a run.

2.21 Be able to have calibration testing and quality control testing performed without excess delay to testing currently in progress.

2.22 The instrument systems shall have on-board reagent refrigeration as required.

2.23 The instrument systems shall have on-board, adjustable, color, touchscreen monitors that are easily readable and icon driven and user friendly.

2.24The Vendor shall provide all necessary printers for the instrument systems and shall be
responsible to replace/repair any broken instrument system printers over the life of the
contract. (Supplies such as paper, cartridges/ink will be the responsibility of theGovernment)
2.25The Vendor shall provide all upgrades to the equipment hardware and operating system
software at no additional cost to the Government during the lifetime of the instrument.These enhancements shall be delivered and installed within 60 days of issuance to thecommercial market.

2.26 As required, all required water systems, primary and backup, to supply deionized water for coagulation analyzers (filters, preventative maintenance, and repair) are the responsibility of the Vendor.

2.27 Safety features to avoid unnecessary exposure to biohazardous and chemical material.

2.28Total equipment footprint when installed in the laboratory shall not impact the
functionality/operations of laboratory.

2.29. Interface Requirements

2.29.1The Vendor shall be responsible for providing all hardware required for theconnection, implementation, and operation of the interface to the
universal interface and any incremental fee that is required each time aninstrument is added to an existing universal interface system.
2.29.2The Vendor shall provide all necessary software support for insuring that
successful interfacing has been established. Specific requirements for the
communication of the data streams will be unique to the instrument systeminvolved and dictated by the manufacturer itself.
2.29.3If a site already has a universal interface system, the Vendor is responsible for
everything leading up to the connection to the software system, including any
incremental fee required to add additional equipment (e.g., licenses, ports/cards,
cables, software, etc.) to the universal interfacing system.

2.29.4 If a site does not have a universal interface and one is needed to optimally interface the instrument, then the Vendor is responsible for the acquisition of the universal interface box and everything else needed to connect with VA computerized hospital information system.

2.29.5If there are any software upgrades in the instrument during its life, the Vendor is
responsible for seeing that the interface can accommodate any changes in thedata stream going to the VA computerized hospital information system.

2.30 Equipment/Analyzer Software

2.30.1 Trigger automatic repeat testing of critical samples.

2.30.2 Trigger reflex testing based on user-definable rules.

2.30.3 Allow for manual add-on testing of samples already loaded onto the instrument.

2.30.4 Track the processing of individual samples; to estimate the completion time of each analyte and to review any completed results on a patient sample, even if all analytes are not yet completed.

2.30.5Display snapshot screens of patient testing queue, patient results, reagent status,
calibration history, and quality control results.

2.30.6 Show real-time on-board reagent inventory.

2.30.7 Alert user of low reagent volumes at user-definable thresholds.

2.30.8 Store calibration curves for at least four different lot numbers per analyte.

2.30.9 Operator may select to run a test on only a specified lot of reagents even though more than one lot has a valid calibration.

2.30.10 Transfer and archive patient results, calibration history, and quality control records onto external media, such as a CD/DVD disk or an external hard drive. Once archived, the on-board memory shall be able to be purged so that the operator can manipulate only the current dataset accumulating since the most recent archive date.

2.30.11 Store and re-transmit patient records, in case of interface downtime up to a minimum of 24 hours or longer.

2.30.12 View Operations Manuals and Troubleshooting Guides on the instrument monitor with pictures, diagrams, and video.

2.30.13 Program sample batch processing.

2.30.14Track and store which tests were performed on which specific instrument(s), per
patient result.

2.30.15 Ability to monitor instrument performance.

2.30.16 A bi-directional, bar-coded computer interface compatible with the VA laboratory information system. The interface (both hardware and software) shall be immediately available for implementation to the VA computerized hospital information system.

2.30.16.1 INTERFACE

Transfer of data is bidirectional and will occur in the following
manner:

DAWNING / INNOVATION

VISTA

(LIS)

INSTRUMENT

2.30.16.2 The following data fields will be collected:

Prime IDSpecimen IDPatient IDPriority
Action code Sample typeCollect dataCollect time
Creation dateCreation timeLast nameFirst name
Middle name SEXBirthdayLocation
AnalyzerStationTest name

2.30.16.3 Data is transferred from VISTA to a Dawning Secure Network Interface (SNI) device, which is then sent to the instrument, using the appropriate format. Once testing is complete, the instrument sends the result back to the SNI which then sends the result back to VISTA in the appropriate format.

2.30.16.4 All testing is performed by Pathology & Laboratory Medicine Service staff using appropriate procedures, access and verify codes. VA sensitive information is stored in the VISTA/LIS database and all records are backed up on disk and stored in a secure, location, (disks locked drawers behind locked doors) per regulations. Data will be available to providers using CPRS system.

2.30.17 Barcode reading accuracy must have less than a 1.0 % failure rate. Must have positive patient identification with barcode verification at analyzer

2.30.18Bar coding of reagents and the ability to track reagent containers throughout the
testing process.

2.30.19 Vendor shall collaborate with lab to write/develop protocols to establish customer configurable rules to enhance workflow management and productivity.

2.30.20Vendor shall assist customer with optimizing operation and utilization of the data
management system to fully integrate desired testing instrumentation enhancing
productivity and management of workflow.
2.30.21An uninterruptible power supply (UPS) with line conditioner for each instrument
provided. (This includes UPS units for sites with automation lines, specimen
management systems, data management systems, refrigerated storage, etc.,) Each
UPS must provide electrical power for a minimum of 15 minutes or longer after
electrical power fails and the system must allow for an automatic controlledshutdown to prevent damage to the instrument and data records. Contractor isresponsible for maintaining UPS systems provided.

2.31 Quality Control Program

2.31.1 Define multiple lots of the same control for simultaneous testing.

2.31.2 Perform quality control testing on all available lots and containers of a specific reagent when that reagent is selected for quality control analysis.

2.31.3 This should be automatic and not by manual selection.

2.31.4 Allow the operator to select which Westgard rules to apply.

2.31.5 Utilize weighted means and moving averages.

2.31.6 View and print daily, weekly, and monthly quality control results.

2.31.7 Document out-of-range quality control values.

2.31.8 Capability to record, store and print required quality control Levy-Jennings graphs., instrument maintenance information, patient demographic information and specimen results.

2.31.9 Capability to detect and alert operator of out-of-range quality control results via
flagged results on QC printout and visual alerts on display monitor.

2.31.10 Quality control material will automatically be run on all lots of those reagents when the respective test is requested.

2.31.11Quality control results will be easily distinguishable i.e., identified by reagent lot
number or similar mechanism, on instrument printout or display monitor.

2.32 Reagent, Consumable, Quality Control Material & Calibrator Requirements

2.32.1 All reagents, buffers, substrates, controls, and calibrators required to run all assays shall be included in the cost-per-reportable-result proposal and shall not be listed as individually priced line items.

2.32.2Reagents shall minimally or not at all, require reagent preparation, including
reconstitution/hydration, mixing components, and/or thawing/warming.

2.32.3 All consumables required to operate the instrument systems for the Amarillo VAHCS and Lubbock CBOC test menu assay-required consumables, shall be included in the cost-per-reportable-result proposal and shall not be priced separately.

2.32.4All Amarillo VAHCS and Lubbock CBOC test menu assay-required calibratorsshall be included in the cost-per-reportable-result proposal and shall not be priced
separately.

2.32.5 Calibration(s) of on-board reagents per lot number should have a minimum stability of two (2) weeks or longer.

2.32.6All Amarillo VAHCS and Lubbock CBOC test menu assay-required vendor
manufactured quality controls shall be included in the cost-per-reportable -resulttest proposal and shall not be priced separately. This does not include 3rd partyquality control materials.

2.32.7 All freight charges are the responsibility of the Vendor.

2.32.8The contractor shall provide the specific deliverables described within the
performance period stated in Section 1.4.1 The instrumentation and tests offered
shall be approved by the Food and Drug Administration (FDA)

2.32.9 Specific Assay Requirements- INR needs to be able to read greater than (>) 10 or above.

2.32.10 Vendor shall provide peer review and data reduction of quality control results to efficiently process approximately 13,050 coagulation tests per annum for AVAHCS in Amarillo, TX, and approximately 1750 coagulation test per annum for Lubbock CBOC in Lubbock, TX.

2.32.11 The vendor shall ship all the reagents, quality control materials, and consumables to:

Amarillo VA Health Care System
6010 Amarillo Blvd., West
Amarillo, TX 79106
Attention: Laboratory

To keep the inventory free of deterioration at the CBOC, the AVAHCS will allot the Lubbock VA CBOC reagents, quality control material, and consumables for no more than 2 weeks at a time upon request to re-supply.

3. ENVIRONMENTAL FACTORS AND UTILITIES REQUIREMENTS

3.1 The heat output of the automation and instrument system components, while operating at maximum capacity, and in conjunction with each other, shall be taken into consideration.

3.2 No piece of equipment shall have a noise output of more than 68 decibels when that equipment is performing at maximum operation.

3.3Hazardous Waste – The Vendor shall provide hazardous waste determination. The
Hazardous Waste Determination is a procedure used to determine whether the by-products (liquid and solid waste) of an analytical process are characterized as a hazardouswaste.
3.4The solid waste created by the use of the proposed Vendor’s materials shall be taken into
consideration. This includes reagent boxes and wrappers, emptied reagent containers, and
used consumable products
3.5208/220V outlets are limited in the Coagulation Department of the Amarillo VAHCS and
Lubbock CBOC. Consideration shall be given to the number of 208/220V outlet requiredfor instrument systems.
3.6*The Vendor shall be responsible for the installation and all service costs of a water
filtration system(s) if required for the use of the analyzer.
3.6.1The Vendor shall be responsible for the costs of replacing, moving modifying, or
reinstalling, the existing water filtration system in the Coagulation Department
at the Amarillo VAHCS lab and Lubbock CBOC lab.
3.6.2 The water filtration system shall be comprised of at least two filtration units,
including individual pumps, which can be operated in tandem or isolated, in theevent one unit is contaminated or broken.
3.6.3 The water filtration system shall be sufficient to meet the maximum hourly water
requirements of all instrument systems connected to it.

3.6.4 The water filtration system shall make Type II laboratory-grade water, meeting the manufacturer’s requirements for the instrument systems.

3.6.5 The water filtration system shall have a reservoir tank of at least 250 liters. This
volume may be shared among multiple water filtration systems.
3.6.6 The water filtration system shall utilize pre-treatment filters, due to the age of the
Amarillo VAHCS and on-going projects to replace the facility’s water lines.
Lubbock CBOC has all new water lines.

3.6.7 The water filtration system shall have leak detection alarms, both audible and visible, and shall have bypass options to isolate individual filtration units.

3.6.8 The water filtration system shall have a spigot or tap, where another laboratory
departments can fill up transport containers of filtered water.
3.7The radio frequency tracking shall not cause harmful interference to other equipment or
communications in the facility.

3.8 System Management

3.8.1 Computer interface compatible with the current VA laboratory information system and existing universal interface.

3.8.2 The fully operational interface (both hardware and software) shall be immediately available for implementation to the VA computerized hospital information system.

3.8.3 The accuracy of the barcode reading must have less than a 1.0 % failure rate.

3.8.3.1Equipment must be able to support multiple barcode formats (Code 39,
Code 128) that may be enabled concurrently.

3.8.3.2 Equipment must accept, at a minimum, 10 characters in specimen identifier that is alpha, numeric, and/or alphanumeric concurrently.

3.8.4 The ability to detect processing errors and provide error notification.

3.8.5The ability to isolate primary analyzers from the processing equipment when
necessary.

3.9 Middleware System: Generally, a separate component/computer that electronically links the testing instrumentation to manage data, results, and workflow (Not to be confused with Data Innovations)

3.9.1The Vendor shall specify where the middleware solution effect (prozone effect)
resides – on an Amarillo VAHCS and Lubbock CBOC network or on aContractor-provided PC/network.
3.9.2 The Vendor shall input initial validation rules and auto-verification rules as
requested by the Amarillo VAHCS and Lubbock CBOC upon initial set-up.

3.9.2.1 The middleware solution shall have the capability to create user- definable rules.

3.9.2.2The middleware solution shall be able to calculate and provide Moving
Averages on patient testing data.

3.9.2.3 Instrument connection to middleware service shall be provided

3.9.3 The Vendor shall provide on-going middleware support to the Amarillo VAHCS and to the Lubbock CBOC for the life of the contract

3.9.3.1 This support shall include assistance with writing future rules, editing and troubleshooting.

3.9.3.2 The Vendor shall provide specific training to three (3) Amarillo VAHC personnel and two (2) Lubbock CBOC on how to create and edit rules, how to configure and manipulate the middleware program, and how to troubleshoot problems with the middleware solution.

3.9.3.3 Training on-site and/or at an off-site location, all costs associated with the training shall be included in the proposed cost-per-reportable result proposal.

3.9.4 The Vendor’s middleware solution shall have a successful history of interface with the Veteran Affair’s VISTA Laboratory Information System.

3.9.5 The Vendor shall provide software updates to the middleware solution as part of the cost-per-test contract proposal.

4. TRAINING REQIREMENTS

4.1The Vendor must provide an instrument(s) training program that is coordinated with and
timely to the equipment installation.
4.2Initial training to include one (1) operator per analyzer(s) and will include training on the
operation of the system, data manipulation, and basic troubleshooting and repair.

4.3 Utilization of the training slots will be mutually agreed upon between the Amarillo VAHCS and Lubbock CBOC and the Vendor.

4.4 Additionally, the Amarillo VAHCS and Lubbock CBOC is requesting four (4) training slots specific to the middleware solution offered in the proposal either to be on-site or off-site.

4.5A training program that involves off-site travel shall include the cost of airfare, ground
transportation, room and board, and training/classroom costs for each participant.
4.6The Contractor shall also provide in-house training for all laboratory shifts during
implementation.

5. BILLING AND INVOICING

5.1.Monthly billing and test report summaries shall begin on the first day of the month and
include the last day of the month.

5.2 VA-FSC shall require the following information in compliance with the Prompt Pay Act and Business Requirements.

5.2.1 Your Taxpayer ID number (TIN)

5.2.2 Your “Remit Address” information

5.2.3 The VA Purchase Order (PO) number

5.2.4 Your contact information: (Personal name, Email, and Phone)

5.2.5 Your VA Point of contact information (Personal name, Email, and Phone)

5.2.6 The Period of Performance dates (POP Beginning and Ending)

5.2.7 All discount information if applicable (Percent and Date Terms)

5.2.8 Reagents used with pricing per unit

5.2.9 No freight charges to be added to the invoice

5.3 Department of Veterans Affairs Financial Service Center:

5.3.1 Phone:1-877-353-9791

5.3.2 Email: vafscched@va.gov

5.4 AVAHCS shall not be responsible for payment of services and or supplies which were not requested Accordance with the contract.

5.5AVAHCS will NOT pay for tests that are not clearly identified by product number on the
invoice.
5.6Invoices are to be separate for Amarillo and Lubbock laboratories but the usage of the
same PO number is acceptable for billing purposes.

5.7 Invoices will be electronically submitted to the Tungsten website at:

5.7.1 http://ww.tungsten-network.com/uk/en/

5.7.2 Tungsten direct vendor support number is 877-489-6135 for VA contracts.

5.8 All invoices submitted through Tungsten to VA-FSC should mirror your current submission of Invoice.

6. SERVICE /MAINTENANCE REQUIREMENTS

6.1A technical assistance center shall be available by telephone 24 hours per day, 7 days per
week with a maximum call back response time of 1 hour.

6.2 Equipment repair service shall be provided 24/7 for AVAHCS Laboratory and 5 days/week between 8am – 5pm for Lubbock CBOC laboratory.

6.3 HOURS OF OPERATION

6.3.1 Normal hours of operations at the VAMC are Monday through Friday from 8:00 am to 4:30 pm, excluding holidays.

6.3.2All work will be performed during normal hours of coverage unless requested or
approved by Chemistry Supervisor or his designee.

6.3.3 Federal Holidays observed by the VAMC are:

New Years' DayLabor Day
Martin Luther King DayColumbus Day
Presidents' DayVeterans' Day
Memorial DayThanksgiving Day
JuneteenthChristmas Day
Independence Day

6.4 Equipment repair response time shall be no more than 24 hours.

6.5 Preventative maintenance will be performed as frequently as published in manufacturer’s operator’s manual and within 2 weeks of the scheduled due date.

6.6 A malfunction incident report shall be furnished upon completion of each repair call. The report shall include, at minimum, the following: date and time notified, date and time of arrival, serial number, type and model number of equipment, time spent for repair, and proof of repair to include documentation of a sample run of quality control verifying acceptable performance.

6.7 Each notification for an emergency repair service call shall be treated as a separate and new service call.

6.8 Support shall include remote management software including diagnostics for equipment. Remote access to equipment is not available at this time.

6.9 Vendor shall not access patient information during service and/or repairs.

7. SUPPPORT FEATRUES

7.1Start-Up Reagents. The Vendor shall provide all reagents, calibrators, controls,
consumable/disposable items, parts, accessories, and any other item required to establish
instruments for acceptable operation.

7.2 The Vendor shall perform/assist with all validation studies listed below at no cost to the Government.

7.2.1 Correlation studies for each analyte

7.2.2 Linearity or Analytical Measurement Range (AMR) Validation shall be performed on proposed instrument(s) for each analyte to validate the reportable range.

7.2.3 The validation of the INR will meet the pharmacy needs of a minimum of 10 and
above.
7.2.4 Precision study using normal and abnormal control material. Intra-VISN facility
variations should be kept at an absolute minimum.

7.2.5 Sensitivity/Specificity: efficiency, sensitivity, false positive rate, and false negative rate

7.2.6 Carryover Studies.

7.2.7 Reference Range- Reference range assessment must be performed for each lab.

7.2.8 Accuracy/Recovery

7.2.9 Calibration Verification

7.3 Method performance/comparison shall be consistent with current CLSI guidelines, College of American Pathologists (CAP) standards and Federal regulations.

7.4All studies performed will be appropriate for the test menu of the respective laboratory to
include citrated plasma.

8. OTHER

8.1Request for instrumentation upgrades or replacement due to workload increase, excessive
instrumentation failures/malfunctions, breakdowns, or service calls shall be evaluated as
needed/annually by the laboratory with communication to the vendor for modification ofthe order. A high incidence of such problems with any equipment/analyzer supplied mayindicate probable non-compliance with the terms of this contract and will entitle thefacility/clinic to its replacement with other analyzer(s) that can produce the requiredcriteria satisfactorily to the user.

8.2 The Vendor shall remove all equipment within 90 days after notification of the expiration of the terms of this agreement but not until the completion of new vendor's equipment installation inclusive of completed cross over studies.

8.3 The Vendor shall be responsible for removing the hard drive and turning it over to the VA for destruction prior to removal of any analyzer.

8.4 The Vendor shall reimburse the facility for EXACT costs/supplies related to tests sent to a referral laboratory when testing is not available through no fault of the facility due to reagent problems, other product issues, or other vendor related factors. The assessed damages shall be applied to the invoice in the form of a credit or deduction.

8.5In the event that the any consumable, reagent, or other necessary item are found to be
defective and unsuitable for use with the vendor's equipment, or the Vendor has failed to
comply with the requirements for routine supply delivery, the Vendor shall deliver the
consumable supplies within a period of 24 hours after receipt of the verbal order forpriority delivery from the facility.
8.6If either circumstance has occurred, the Vendor shall deliver to the facility, in the most
expeditious manner possible, without additional cost to the facility, the necessaryconsumables insufficient quantity so testing is not delayed.

8.7 This order should assist the Department of Veterans Affairs to pursue the goal of being a good steward in our community by eliminating, minimizing, or mitigating adverse environmental impacts.

8.8The following chemicals have been targeted by the EPA specifically for reductions and
feasible elimination. Please list any reagents (and in what concentration) that contain the
following chemicals:
BenzeneCarbon tetrachloride
ChloroformDichloromethane
Methyl ethyl ketoneToluene
Methyl isobutyl ketoneXylenes
Tetrachloro-ethyleneCadmium
1,1,1-Trichloro-ethaneChromium
Trichloro-ethyleneCyanide
LeadMercury
Nickel

9. CONFIDENTIALITY AND NONDISCLOSURE

It is agreed that:

9.1 The preliminary and final deliverables, and all associated working papers, application source code, and other material deemed relevant by VA which have been generated by the Vendor in the performance of this task order, are the exclusive property of the U.S. Government and shall be submitted to the CO at the conclusion of the task order.

9.2 The CO will be the sole authorized official to release, verbally or in writing, any data, draft deliverables, final deliverables, or any other written or printed materials pertaining to this task order. No information shall be released by the Vendor. Any request for information relating to this task order, presented to the contractor, shall be submitted to the CO for response.

9.3. Press releases, marketing material, or any other printed or electronic documentation related to this project, shall not be publicized without the written approval of the CO.

10. CONTRACTOR SECURITY REQUIREMENTS

10.1 The Vendor requires no access to AVAHCS or any VA information system. The Vendor’s analyzers will be compatible and interfaced to the AVAHCS information system. There will be supervised access when the Vendor is physically present for technical support, service calls, and scheduled preventative maintenance.

10.2 NO VA DATA OF ANY TYPE SHALL BE TRANSFERRED FROM THE VA.

10.3 The C&A requirements do not apply. A Security Accreditation Package is not required.

11. RECORDS MANAGEMENT

11.1 All records (administrative and program specific for AMA/LUB) created during the period of the contract belongs to AVAHCS and must be returned to AVAHCS at the end of the contract.

VHA Supplemental Contract Requirements for Ensuring Adequate COVID-19 Safety Protocols for Federal Contractors

1. Contractor employees who work in or travel to VHA locations must comply with the following:

a. Documentation requirements:
1) If fully vaccinated, shall show proof of vaccination.
i. NOTE: Acceptable proof of vaccination includes a signed record ofimmunization from a health care provider or pharmacy, a copy of the COVID-19Vaccination Record Card (CDC Form MLS-319813_r, published on September3, 2020), or a copy of medical records documenting the vaccination.
2)If unvaccinated and granted a medical or religious exception, shall show negativeCOVID-19 test results dated within three calendar days prior to desired entrydate. Test must be approved by the Food and Drug Administration (FDA) foremergency use or full approval. This includes tests available by a doctor’s orderor an FDA approved over-the-counter test.

3) Documentation cited in this section shall be digitally or physically maintained on each contractor employee while in a VA facility and is subject to inspection prior to entry to VA facilities and after entry for spot inspections by Contracting Officer Representatives (CORs) or other hospital personnel.

4) Documentation will not be collected by the VA; contractors shall, at all times, adhere to and ensure compliance with federal laws designed to protect contractor employee health information and personally identifiable information.

2.Contractor employees are subject to daily screening for COVID-19 and may be deniedentry to VA facilities if they fail to pass screening protocols. As part of the screening processcontractors may be asked screening questions found on the COVID-19 Screening Tool.Check regularly for updates.
a.Contractor employees who work away from VA locations, but who will have directcontact with VA patients shall self-screen utilizing the COVID-19 Screening Tool, inadvance, each day that they will have direct patient contact and in accordance with theirperson or persons who coordinate COVID-19 workplace safety efforts at coveredcontractor workplaces. Contractors shall, at all times, adhere to and ensure compliancewith federal laws designed to protect contractor employee health information andpersonally identifiable information.

Contractor must immediately notify their COR or Contracting Officer if contract performance is jeopardized due to contractor employees being denied entry into VA Facilities.

*= Required Field
Sources Sought Notice

Sources Sought Notice

File details come from the government source that posted it. Updated .